Urinary tract infections (UTI) are one of the most common infections with 15,000-20,000 diagnosed cases annually at hospitals in Denmark alone. Up to 80% of the hospital-acquired urinary tract infections are associated with the use of a catheter. This is a huge disadvantage to the patient with increased discomfort, morbidity and mortality. Furthermore, the staff at the specific department is burdened with the extended periods of hospitalization, and, as a consequence, more unnecessary work. We are trying to solve this problem by preventing catheter-associated UTIs - for the hospitals and the patient.
| Website | http://www.viobac.dk |
| Employees | 5 (1 on RocketReach) |
| Founded | 2018 |
| Technologies |
JavaScript
,
HTML
,
Twitter
+5 more
(view full list)
|
| Industry | Medical Equipment Manufacturing |
| Keywords | Phage Therapy, Urinary Tract Infection, Antimicrobial, Infection Prevention, Uti Treatment, Hospital Acquired Infections, Urology, Antibacterial, Bacterial Infections, Biotechnology, Microbiology, Medical Devices, Prevention, Pharmaceutical, Healthcare, Treatment |
| Competitors | BASF, Ecolab, Lonza, Sealed Air Corporation, Albemarle Corporation, STERIS, Arkema, Diversey Nederland, Clariant, Thompson & Morgan +22 more (view full list) |
Looking for a particular VIOBAC employee's phone or email?
VIOBAC Questions
1 people are employed at VIOBAC.
Related Companies
